Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 07, 2023 Filed Nov 9, 2023 18:42 UTC |
Peters Stanley W IIIPresident AS and AET
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,200 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-027084 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,300 Underlying: Common Stock · 1,200 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 18:42 UTC |
Peters Stanley W IIIPresident AS and AET
|
SaleCommon Stock | 1,200 | $102.40 | $122,874.00 |
DisclosureSEC source: 0001127602-23-027084 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 18:42 UTC |
Peters Stanley W IIIPresident AS and AET
|
Exercise / conversionCommon Stock | 1,200 | $41.93 | $50,316.00 |
DisclosureSEC source: 0001127602-23-027084 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 21:38 UTC |
Peters Stanley W IIIPresident AS and AET
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-024253 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 2,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 21:38 UTC |
Peters Stanley W IIIPresident AS and AET
|
SaleCommon Stock | 2,000 | $107.31 | $214,629.20 |
DisclosureSEC source: 0001127602-23-024253 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.73. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 21:38 UTC |
Peters Stanley W IIIPresident AS and AET
|
Exercise / conversionCommon Stock | 2,000 | $41.93 | $83,860.00 |
DisclosureSEC source: 0001127602-23-024253 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · President AS and AET 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 22:26 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 1,355 | $112.00 | $151,759.73 |
DisclosureSEC source: 0001127602-23-022861 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.890 to $112.170. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:29 UTC |
Cohen Heather LEVP & Chief HR & Legal Officer
|
GrantCommon Stock | 16 | $129.10 | $2,065.60 |
DisclosureSEC source: 0001127602-23-020082 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP & Chief HR & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,370 Read SEC document |
| June 17, 2023 Filed Jun 21, 2023 22:35 UTC |
Lalomia BrentVice President QA and RA
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019194 · form4.xml · derivative · entry 3 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2029-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| June 17, 2023 Filed Jun 21, 2023 22:35 UTC |
Lalomia BrentVice President QA and RA
|
Tax withholdingCommon Stock | 71 | $135.64 | $9,630.44 |
DisclosureSEC source: 0001127602-23-019194 · form4.xml · nonDerivative · entry 2 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 908.057 Read SEC document |
| June 17, 2023 Filed Jun 21, 2023 22:35 UTC |
Lalomia BrentVice President QA and RA
|
Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019194 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 979.057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:31 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
SaleCommon Stock | 1,000 | $136.00 | $136,000.00 |
DisclosureSEC source: 0001127602-23-018880 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,299 Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 20:52 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 4,500 | $0.00 Strike: $55.42 | $0.00 |
DisclosureSEC source: 0001127602-23-018593 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires 2025-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 20:52 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Tax withholdingCommon Stock | 2,650 | $132.44 | $350,966.00 |
DisclosureSEC source: 0001127602-23-018593 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,711 Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 20:52 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionCommon Stock | 4,500 | $55.42 | $249,390.00 |
DisclosureSEC source: 0001127602-23-018593 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:40 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-018442 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 5,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:40 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 5,000 | $131.14 | $655,676.00 |
DisclosureSEC source: 0001127602-23-018442 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.07 to $131.19. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:40 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionCommon Stock | 5,000 | $41.93 | $209,650.00 |
DisclosureSEC source: 0001127602-23-018442 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:39 UTC |
Ferrell John D.Executive Vice President - HR
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,700 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-23-018440 · form4.xml · derivative · entry 3 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,700 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:39 UTC |
Ferrell John D.Executive Vice President - HR
|
SaleCommon Stock | 1,700 | $131.81 | $224,077.00 |
DisclosureSEC source: 0001127602-23-018440 · form4.xml · nonDerivative · entry 2 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 702 Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 20:39 UTC |
Ferrell John D.Executive Vice President - HR
|
Exercise / conversionCommon Stock | 1,700 | $41.93 | $71,281.00 |
DisclosureSEC source: 0001127602-23-018440 · form4.xml · nonDerivative · entry 1 Ferrell John D. · CIK 0001980620 · Executive Vice President - HR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:39 UTC |
Concannon BrianDirector
|
SaleCommon Stock | 812 | $129.01 | $104,756.12 |
DisclosureSEC source: 0001127602-23-018316 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,335 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.95 to $129.18. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:45 UTC |
Workman John LDirector
|
GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017626 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:45 UTC |
Workman John LDirector
|
GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017626 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:45 UTC |
Workman John LDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017626 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:45 UTC |
Workman John LDirector
|
Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017626 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:42 UTC |
Schwarzentraub Barbara JDirector
|
GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017625 · form4.xml · derivative · entry 4 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:42 UTC |
Schwarzentraub Barbara JDirector
|
GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017625 · form4.xml · derivative · entry 3 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:42 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017625 · form4.xml · derivative · entry 2 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:42 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017625 · form4.xml · nonDerivative · entry 1 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:40 UTC |
Lande Jerome J.Director
|
GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017624 · form4.xml · derivative · entry 4 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:40 UTC |
Lande Jerome J.Director
|
GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017624 · form4.xml · derivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:40 UTC |
Lande Jerome J.Director
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017624 · form4.xml · derivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:40 UTC |
Lande Jerome J.Director
|
Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017624 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:37 UTC |
Farkas CharlesDirector
|
GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017622 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:37 UTC |
Farkas CharlesDirector
|
GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017622 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:37 UTC |
Farkas CharlesDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017622 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:37 UTC |
Farkas CharlesDirector
|
Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017622 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:32 UTC |
Council LaVerne HDirector
|
GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017618 · form4.xml · derivative · entry 4 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:32 UTC |
Council LaVerne HDirector
|
GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017618 · form4.xml · derivative · entry 3 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:32 UTC |
Council LaVerne HDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017618 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:32 UTC |
Council LaVerne HDirector
|
Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017618 · form4.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:28 UTC |
Concannon BrianDirector
|
GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017613 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:28 UTC |
Concannon BrianDirector
|
GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017613 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:28 UTC |
Concannon BrianDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017613 · form4.xml · derivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:28 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017613 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:26 UTC |
Bronson David M.Director
|
GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017609 · form4.xml · derivative · entry 4 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:26 UTC |
Bronson David M.Director
|
GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017609 · form4.xml · derivative · entry 3 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:26 UTC |
Bronson David M.Director
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017609 · form4.xml · derivative · entry 2 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:26 UTC |
Bronson David M.Director
|
Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017609 · form4.xml · nonDerivative · entry 1 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.